Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
RFI – Supporting Development of Therapeutics for Rare and Neglected Diseases Contracts + Grants November 29, 2016 …
Zika in Fetal Brain Tissue Responds to Popular Antibiotic Azithromycin Featured News November 29, 2016 …
Intravenous Brincidofovir May Improve Countermeasure’s Tolerability Industry News November 22, 2016 …
Liposomal Ciprofloxacin as Broad-Spectrum Bioterrorism Countermeasures Featured News October 20, 2016 …
Ricin Vaccine Featured at Rare Diseases and Orphan Products Summit Medical Countermeasures October 12, 2016 …
DoD to Study Omadacycline as Countermeasure for Plague, Anthrax Contracts + Grants October 12, 2016 …
